Related references
Note: Only part of the references are listed.The anti-inflammatory and antiviral properties of anionic pulmonary surfactant phospholipids
Mari Numata et al.
IMMUNOLOGICAL REVIEWS (2023)
Adsorption of SARS-CoV-2 Spike (N501Y) RBD to Human Angiotensin-Converting Enzyme 2 at a Lipid/Water Interface
Harison Rozak et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2023)
Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein
Afsaneh Sadremomtaz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Emulation of the structure of the Saposin protein fold by a lung surfactant peptide construct of surfactant Protein B
Alan J. Waring et al.
PLOS ONE (2022)
The inhibitory effect of a coronavirus spike protein fragment with ACE2
Emanuel K. Peter et al.
BIOPHYSICAL JOURNAL (2021)
Structural and functional stability of the sulfur-free surfactant protein B peptide mimic B-YL in synthetic surfactant lipids
Frans J. Walther et al.
BMC PULMONARY MEDICINE (2021)
Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Interactions
Christopher J. Day et al.
MBIO (2021)
Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19-related Acute Respiratory Distress Syndrome
Ludovic Gerard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Biophysical properties of the isolated spike protein binding helix of human ACE2
Anirban Das et al.
BIOPHYSICAL JOURNAL (2021)
Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury
Francesco Cattel et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2021)
Structural Biology in the Clouds: The WeNMR-EOSC Ecosystem
Rodrigo Honorato et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Surfactant therapy for COVID-19 related ARDS: a retrospective case-control pilot study
Simone Piva et al.
RESPIRATORY RESEARCH (2021)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics
Sonya VanPatten et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion
Donald J. Benton et al.
NATURE (2020)
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Longxing Cao et al.
SCIENCE (2020)
Advances in synthetic lung surfactant protein technology
Frans J. Walther et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2019)
PRODIGY: a web server for predicting the binding affinity of protein-protein complexes
Li C. Xue et al.
BIOINFORMATICS (2016)
The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes
G. C. P. van Zundert et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Contacts-based prediction of binding affinity in protein-protein complexes
Anna Vangone et al.
ELIFE (2015)
Surface plasmon resonance spectroscopy for characterisation of membrane protein-ligand interactions and its potential for drug discovery
Simon G. Patching
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
Sequence-specific determination of protein and peptide concentrations by absorbance at 205 nm
Nicholas J. Anthis et al.
PROTEIN SCIENCE (2013)
A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2
Anna-Winona Struck et al.
ANTIVIRAL RESEARCH (2012)
Critical Structural and Functional Roles for the N-Terminal Insertion Sequence in Surfactant Protein B Analogs
Frans J. Walther et al.
PLOS ONE (2010)